Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds.
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, but they don't work for up to 4 of every 10 patients. New research led by ...
C-T-P, compound-target-pathway; DL, drug-likeness; GO, gene ontology; OB, oral bioavailability; PPI, protein-protein interaction; RA, rheumatoid arthritis; TCMSP ...
Please provide your email address to receive an email when new articles are posted on . Strictly controlling inflammation can heal bone erosions in rheumatoid arthritis, a process accompanied by ...
Interleukin 1 receptor accessory protein (IL1RAP) is a receptor that activates signaling pathways triggered by IL1α/β, IL33 and IL36α/β/γ, which are involved in several autoimmune or inflammatory ...
Itaconate and its derivatives regulate immune signaling in activated macrophages by modulating both pro-inflammatory and anti-inflammatory pathways. 4-Octyl itaconate stabilizes NFE2L2 by alkylating ...
Share on Pinterest Recent evidence suggests that the gut plays a key role in rheumatoid arthritis. Image credit: koganami studio/Stocksy. A recent review of studies on gut dysbiosis (imbalanced gut) ...
Rheumatoid arthritis care faces challenges like workforce shortages and delays in diagnosis and treatment initiation. Effective interventions include using technology, streamlining care processes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results